OUR BLOG
Trends and insights shaping pharma and medical affairs
October 28, 2026
How an MSL Records a Scientific Exchange: What Goes in the Note and When
An MSL walks out of a meeting with an academic oncologist and sits in the car for a minute before the next drive. The conversation covered the subgroup data from the Phase 3 readout. Near the end,.
October 26, 2026
How Medical Affairs Covers a Congress, From the Coverage Plan to the Readout
The congress is in nine days. The agenda sits in a spreadsheet with four hundred rows, the travel list was set in August, and three MSLs have each flagged the same plenary as the one they want..
October 21, 2026
Pharma Speaker Programs: Six Decisions to Make Before the First Invite
A brand team plans forty dinner programs for the year. The speakers are the physicians the sales team knows best, the deck is last year's with a new date on the cover, and half the room attended in.
OUR CASE STUDIES
Success stories highlighting TikaMobile’s impact
Apr
28
Product Launch Timeline for Rare Disease & Oncology Indications: T-24 Months to Launch
When working with companies that are preparing for their product launch, we get asked a lot of questions. Although the specific questions vary from client to client, there are some that are consistently on the list of nearly every company we speak with.
April 28, 2023